IL-15, while not able to protect NK cells alone, enhanced the recovery and function of cryopreserved NK cells when used in combination with IL-18, achieving equipotency in a cytotoxicity assay, and in vivo in a model of disseminated B-cell lymphoma. Here, IL15 is linked to B-cell non-Hodgkin lymphoma.